fbpx

< Back to Thought Leadership

340B Hospitals Affected by COVID-19 Update

Great news for 340B Hospitals affected by COVID-19. On March 15, 2022, President Biden signed into law the $1.5 trillion Consolidated Appropriations Acts, 2022.

This bill allows Hospitals that have lost eligibility due to a decrease in their Medicare disproportionate share (DSH) percentage as a result of the COVID-19 public health emergency to regain access to 340B discounts. This does not include any retrospective eligibility and is only temporary. Depending on the fiscal year end of the Hospital, this relief could cover multiple calendar years.

How to Tell if Your Organization Qualifies 

As a 340B Hospital affected by COVID-19, the following stipulations must be met to qualify for relief:

  • The Hospital must have been eligible for the 340B program prior to the COVID-19 public health emergency (January 31, 2020).
  • The Hospital must have lost eligibility during the Medicare cost reporting periods of 2020, 2021, and/or ending December 31, 2022.
  • The Hospital must otherwise meet the requirements of being a covered entity and is compliant with all other components of the 340B Program.
  • The Hospital must attest to the HHS Secretary the loss of 340B eligibility was the result of the impact to the Hospital in response to or because of the COVID-19 public health emergency.
  • This impact resulted in a drop in DSH percentage below the participation minimum percentage requirement.

Contact Us

If you have any questions regarding your Hospital’s ability to take advantage of this opportunity or any other issues related to the 340B Program, please contact one of our Apexus certified 340B experts or your local Blue & Co. Advisor.

Kyle Smith, CPA, Director
317.713.7957

Jason Prokopik, PharmD, Manager
317.713.7916

Chad Downing, RPh, Senior Consultant
502.727.9664

Share this article

No Tax on Tips and Overtime? The One Big Beautiful Bill Explained for Employers

The One Big Beautiful Bill brings sweeping changes to employer reporting and compensation practices — and understanding the details is critical to avoiding costly mistakes. In this recorded webinar, Blue […]

Learn More
accounting for tariffs

Accounting for Tariffs: Inventory Implications and Strategic Considerations

By Patrick Brown, CPA, Director of Manufacturing Services at Blue & Co. Industries around the world, particularly those that rely on imported products, continue to face challenges related to tariffs. […]

Learn More
New 340B Rebate Model Pilot Program: What to Know

New 340B Rebate Model Pilot Program: What to Know

The Health Resources and Services Administration (HRSA) has approved a 340B Rebate Model Pilot Program that will significantly change how 340B discounts are accessed for covered entities for certain medications.  […]

Learn More
Share this article
Share this article